Abstract
We consider that from the wound to the healing process, the physiology point key to linkage of the process is still unclear. The process from inflammation to the wound healing is divided into three phases: (1) inflammation process, (2) tissue formation, and (3) tissue remodeling. The inflammation program includes cell produced related factors and immune cells infiltration. We thought the inflammation factors that may be also involved in the followed healing process. But the question is “what kind of factor is the major key involved in the end of the inflammation then to initiate the healing.” We suspect that the apoptosis of immune cell may be the major key to end of inflammation and to initiate the healing.
INTRODUCTION
Wound healing is a complex process involving soluble mediators, blood cells, extracellular matrix, and parenchymal cells (Singer and Clark, 1999; Bullers et al., 2012; Pesce et al., 2013). The process from inflammation to the wound healing is divided into three phases: (1) inflammation process, (2) tissue formation, and (3) tissue remodeling (Figure 1; Eming et al., 2007). The inflammatory phase is marked by platelet accumulation, coagulation, and leukocyte migration. The tissue formation is characterized by re-epithelialization, angiogenesis, fibroplasia, and wound contraction. Finally, the remodeling phase takes place over a period of months, during which the dermis responds to injury with the production of collagen and matrix proteins and then returns to its pre-injury phenotype (Kirsner and Eaglstein, 1993; Castillo-Briceno et al., 2011; Bainbridge, 2013). The normal healing response begins the moment the tissue is injured. Peripheral blood components filtrated into the site of injury, the platelets contact with exposed collagen and other elements of the extracellular matrix through the process from inflammation to wound healing (Diegelmann and Evans, 2004). This contact triggers the platelets to release clotting factors as well as essential growth factors and cytokines such as platelet-derived growth factor (PDGF), such as stimulation of DNA synthesis and chemotaxis of fibroblasts moreover smooth muscle cells to induce the production of collagen, glycosaminoglycan, and collagenase by fibroblasts through the wound healing process (Lynch et al., 1987; Price et al., 2004; Tettamanti et al., 2004). Furthermore, PDGF appears to transduce its signal through wound macrophages and may trigger the activation of feedback loops and synthesis of endogenous wound PDGF and other growth factors, thereby enhancing the cascade of tissue repair processes required for a fully healed wound (Pierce et al., 1991). In a normal response to injury, platelet aggregation and degranulation of the earliest events in an inflammatory response trigger the release of numerous inflammatory mediators including transforming growth factor-β (TGF-β) from the granules (Wahl et al., 1989; Tatler and Jenkins, 2012; Christmann et al., 2013). TGF-β is implicated in pathogenic fibrotic conditions in kidney, liver, and lung disease, and in scarring of skin wounds as well (Martin, 1997; Sgonc and Gruber, 2013). Accumulating evidence indicates that TGF-β affects integrin-mediated cell adhesion and migration by regulating the expression of integrins, their ligands and integrin-associated proteins (Margadant and Sonnenberg, 2010). Research indicated that a synthetic TGF-β is effective in accelerating wound healing and reducing scarring in pig skin burn, pig skin excision, and rabbit skin excision injury models (Huang et al., 2002).
FIGURE 1
INFLAMMATION PROCESS
Inflammation is known to be a crucial adaptive response for animals, and the mechanism is a complex interaction with molecular mediators even the functions of immune cells in a microenvironment through a response that occurs at all levels of biological organization (Allavena et al., 2008). In this process, cooperation among cells and mediators occurs, and a wide range of factors are involved in the classical immune response, including the stage of the inflammation process; the tissue or organ involved; and whether the inflammation is acute and resolving or chronic and non-resolving (Punchard et al., 2004). The inflammation process involves vascular permeability, active migration of blood cells, and the passage of plasma constituents into injurious tissue (Maslinska and Gajewski, 1998). Through the infiltration of immune cells, studies have shown that the inflammation process plays a crucial role in atherosclerosis (Sbarsi et al., 2007). Blood leukocytes, mediators of host defenses and inflammation, localize in the earliest lesions of atherosclerosis in experimental animals. The study of inflammation in atherosclerosis has afforded considerable new insight into the mechanisms underlying the recruitment of leukocytes (Libby et al., 2002). Recently, studies have indicated the role of inflammation in Alzheimer’s disease (AD; Schott and Revesz, 2013). Inflammatory components related to AD neuroinflammation include brain cells, such as microglia and astrocytes, the complement system, and cytokines and chemokines (Rubio-Perez and Morillas-Ruiz, 2012). Regarding cancer development (Gregory, 2013), pro-inflammatory cytokines, including interleukin (IL)-1α, IL-1β, IL-6, IL-8, IL-18, chemokines, matrix metallopeptidase (MMP)-9, and vascular endothelial growth factor (VEGF) are primarily regulated by the transcription factor nuclear factor (NF)-kB, which is active in most tumors and is induced by carcinogens (Aggarwal et al., 2006). Cutaneous wound repair is a tightly regulated and dynamic process involving blood clotting, inflammation, formation of new tissue, and tissue remodeling (Muller et al., 2012). Thrombin is the protease involved in blood coagulation. Its deregulation can lead to hemostatic abnormalities, which range from subtle subclinical to serious life-threatening coagulopathies, i.e., during septicemia (Danckwardt et al., 2013). Inflammation and blood coagulation are the part of the innate host protection mechanism on vascular injury, infection or other wound. Not only the cell of the innate immune system but also activated endothelial cells and platelets are actively involved in acute and chronic inflammation: they release of pro-inflammatory mediators, expose adhesion molecules and receptors, proteases and its inhibitors, clotting factors and associated proteins, and recruit leukocytes (Strukova, 2006). In the process, PAR family serve as sensors of serine proteinases of the blood clotting system in the target cells involved in inflammation. Activation of PAR-1 by thrombin and of PAR-2 by factor leads to a rapid expression and exposure on the membrane of endothelial cells of both adhesive proteins that mediate an acute inflammatory reaction and of the tissue factor that initiates the blood coagulation cascade.(Dugina et al., 2002).
MEDIATORS OF INFLAMMATION
In the inflammation, microenvironment is related to cellular trans-differentiation, migration, proliferation, survival, and extracellular matrix formation. The growth factors likely to be involved are PDGF, TNF-α and TNF-β, HGF, TGF-β2, epidermal growth factor (EGF), and fibroblast growth factor (FGF). Cytokines such as IL-1, IL-6, IL-8, IL-10, and interferon gamma (INF-γ) are also thought to play a role (Morescalchi et al., 2013). It is clearly a balance between appropriate fibroblast activation and the fibrosis that results from their continuing activation. Multiple growth factors have been implicated in fibroblast migration and activation, but much attention has been recently focused on the PDGF family of growth factors and their cognate receptors (PDGFRs; Nemenoff, 2012). Research has documented that PDGF exerts autocrine, mitogenic effect on keratinocytes to support epidermal proliferation and stabilization of the dermoepidermal junction during wound closure. In addition, it stimulates vessel maturation by recruitment and differentiation of pericytes to the immature-endothelial channels (Hellberg et al., 2010).
Studies have investigated the cytokines involved in the inflammation response by using various animal models. The expression of pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNF)-α, is significantly increased in the adipocytes of obese animals (ob/ob mouse, db/db mouse, and fa/fa Zucker rat; Hotamisligil et al., 1993). The activation of TNF-α might induce leukocytes express adhesion molecules on the cell surface (Dunne et al., 2003; Bruderer et al., 2013; Li et al., 2013), leading to diapedesis through individual vascular endothelial cells (Carman and Springer, 2004). IL-6 is an adipokine (Fried et al., 1998) thought to be a mediator of inflammation (Xing et al., 1998; Deng et al., 2012; Tang et al., 2012) that is produced by adipose tissue and liver-resident macrophages that are activated in response to hepatocyte death (Sakurai et al., 2008). IL-6-deficient mice exhibit a marked decrease in inflammatory response, granulation tissue formation, and re-epithelialization (Gallucci et al., 2000). The IL-1 family, which includes IL-1α and IL-1β, exhibits strong pro-inflammatory activities and plays a major role in host responses to exogenous and endogenous noxious stimuli (Gabay et al., 2010). IL-1 induces the expression of adhesion molecules on endothelial cells and elicits stromal cells to release chemokines that promote the recruitment of inflammatory cells at the inflammation site (Dinarello, 1996; Chang et al., 2012; Hu et al., 2012). Such inflammation occurs significantly in cases of comorbidity and might contribute to the increased risk of developing cardiovascular accidents observed in these patients (Carpagnano et al., 2010). IL-10, a cytokine with anti-inflammatory properties, plays a central role in infection that involves limiting the immune response to pathogens and thereby preventing damage to the host (Saraiva and O’Garra, 2010). Recently, research has shown that IL-10 and related cytokines can facilitate the tissue-healing process in injuries caused by infection or inflammation (Ouyang et al., 2011). According to these studies, mediators thought to be involved in the regulation of inflammation responses such as leukocyte recruitment, adhesion molecule expression, and wound healing in the late phase of inflammation.
IMMUNE CELL-WOUND HEALING
Immune cells are involved in virtually every aspect of the wound repair process, from the initial stages where they participate in hemostasis and work to prevent infection to later stages where they drive scar formation (Wilgus, 2008). Evidence supporting a central role for T lymphocytes in the control of wound healing is provided by studies which examine the in vivo effects of alternate forms of T cell manipulation on various parameters of healing (Barbul and Regan, 1990) and Neutrophils as important to wound healing as they help control infection, however, they also release harmful enzymes which damage healthy tissue surrounding the wound site (Brubaker et al., 2011). Investigations have enumerated many of the specific proteins that are produced by wound macrophages at the site of injury. These include the following: (1) chemoattractants that recruit and activate additional macrophages at the site of injury, (2) growth factors that promote cellular proliferation and protein synthesis, (3) proteases and extra-cellular matrix molecules, and (4) factors that may restrain tissue growth once repair is completed (DiPietro, 1995). Neutrophils arrive first within a few minutes, followed by monocytes and lymphocytes. They produce a wide variety of proteinases and reactive oxygen species as a defense against contaminating microorganisms, and they are involved in the phagocytosis of cell debris. Neutrophil play a role as primarily phagocytosis appearing approximately 24 h after injury and contribute to decreasing the infection in the wound. Neutrophils are not paramount to the process of wound healing or collagen synthesis (Park and Barbul, 2004). Research has been shown a role of neutrophil in wound healing for the production of neutrophil growth factors, such as granulocyte/macrophage colony-stimulating factor (GM-CSF; Canturk et al., 2001). Experiments with cultures of keratinocytes established from -/- and +/+ mice revealed a retardation in wound closure in CXCR2 -/-keratinocytes, role for this receptor on keratinocytes in epithelial resurfacing that is independent of neutrophil recruitment (Devalaraja et al., 2000). In the resolution and regeneration stages, macrophages appear to remove large cell debris as well as apoptotic neutrophils, the key scavengers for resolving inflammation and facilitating tissue regrowth, furthermore, experiment illustrated that the depletion of macrophages in zebrafish model leads to the delay of the clearance of cell debris, decrease of regeneration speed, and formation of vacuoles in the regenerating fin (Li et al., 2012). Recently, research has shown that wound healing requires a coordinated interplay among cells, growth factors, and extracellular matrix proteins. Central to this process is the endogenous mesenchymal stem cell (MSC), which coordinates the repair response by recruiting other host cells and secreting growth factors and matrix proteins. MSCs are self-renewing multipotent stem cells that can differentiate into various lineages of mesenchymal origin such as bone, cartilage, tendon, and fat (Maxson et al., 2012).
APOPTOTIC CELL-WOUND HEALING
Evidence illustrated that apoptosis is involved in the resolution of various phases of tissue repair. In the early phases of tissue repair, inflammatory cells underwent apoptosis starting as early as 12 h after wound injured (Brown et al., 1997). Examined apoptotic patterns in cells in open wounds created in rats, found that apoptosis marked observed in the inflammatory cells of the scab. In this research found that apoptosis in myofibroblasts initiated on day 12, peaked at day 20, and resolved at day 60. These findings suggest that myofibroblast apoptosis initiated about the same time at the end of the wound following to the healing (Desmouliere et al., 1995). Stromal keratocyte apoptosis has been well-characterized as an early initiating event of the corneal wound healing response, triggering subsequent cellular processes that include bone marrow-derived cell infiltration, proliferation, and migration of residual keratocyte cells, and, in some circumstances, generation of myofibroblast cells (Wilson et al., 2007). Impaired phagocytosis of apoptotic neutrophils by Vav3-/- (guanine-nucleotide exchange factors implicated in leukocyte functions by relaying signals from immune response receptors and integrins to Rho-GTPases) macrophages was causal for their reduced release of active TGF-β1, for decreased myofibroblasts differentiation and myofibroblast-driven wound contraction to cause the situation of delayed wound healing (Sindrilaru et al., 2009). Apoptotic cells released growth signals that stimulated the proliferation of progenitor or stem cells by caspases 3 and 7 proteases which involves the caspase-mediated activation of phospholipase A2 and the subsequent production and release of the lipid signal prostaglandin E2, a stimulator of cell proliferation and mice lacking either of these caspases were deficient in skin wound healing (Li et al., 2010). We thought the inflammation factors that may be also involved in the followed healing process. But the question is “what kind of factor is the major key involved in the end of the inflammation then to initiate the healing.” We suspect that the apoptosis of immune cell may be the major key to end of inflammation and to initiate the healing as shown in Figure 2.
FIGURE 2
CONCLUSION
We hypothesized that the key point to end of the inflammation is the apoptotic activity of immune cells. Apoptosis is considered a vital component of various processes including normal cell turnover, proper development and functioning of the immune system, hormone-dependent atrophy, embryonic development, and chemical-induced cell death (Elmore, 2007). In the inflammation response, the mediators induce the infiltration of activated immune cells into inflammation site to protect the tissue against the pathogen infection. In the end of the inflammation, we can observe the apoptosis of the immune cells and the apoptotic cells cleared by macrophages. We thought that clearance by macrophages of cells apoptosis is a key point phenomenon associated with actively tissue formation from wound inflammation.
Statements
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
REFERENCES
1
AggarwalB. B.ShishodiaS.SandurS. K.PandeyM. K.SethiG. (2006). Inflammation and cancer: how hot is the link?Biochem. Pharmacol. 721605–1621. 10.1016/j.bcp.2006.06.029
2
AllavenaP.SicaA.SolinasG.PortaC.MantovaniA. (2008). The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.Crit. Rev. Oncol. Hematol.661–9. 10.1016/j.critrevonc.2007.07.004
3
BainbridgeP. (2013). Wound healing and the role of fibroblasts.J. Wound Care22407–412.
4
BarbulA.ReganM. C. (1990). The regulatory role of lymphocytes-T in wound-healing.J. Trauma-Injury Infect. Crit. Care30S97–S100. 10.1097/00005373-199012001-00021
5
BrownD. L.KaoW. W. Y.GreenhalghD. G. (1997). Apoptosis down-regulates inflammation under the advancing epithelial wound edge: Delayed patterns in diabetes and improvement with topical growth factors.Surgery121372–380. 10.1016/S0039-6060(97)90306-8
6
BrubakerA. L.SchneiderD. F.KovacsE. J. (2011). Neutrophils and natural killer T cells as negative regulators of wound healing.Expert. Rev. Dermatol.65–8. 10.1586/edm.10.66
7
BrudererM.AliniM.StoddartM. J. (2013). Role of HOXA9 and VEZF1 in endothelial biology.J. Vasc. Res.50265–278. 10.1159/000353287
8
BullersS.BerryH.InghamE.SouthgateJ. (2012). The resolution of inflammation during the regeneration of biological scaffolds by human tissue.J. Tissue Eng. Regen. Med.6218–218.
9
CanturkN. Z.EsenN.VuralB.CanturkZ.KirkaliG.OktayG.et al (2001). The relationship between neutrophils and incisional wound healing.Skin Pharmacol. Appl. Skin Physiol.14108–116. 10.1159/000056340
10
CarmanC. V.SpringerT. A. (2004). A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them.J. Cell Biol.167377–388. 10.1083/jcb.200404129
11
CarpagnanoG. E.SpanevelloA.SabatoR.DepaloA.PalladinoG. P.BergantinoL.et al (2010). Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8.Transl. Res.15535–43. 10.1016/j.trsl.2009.09.004
12
Castillo-BricenoP.BihanD.NilgesM.HamaiaS.MeseguerJ.Garcia-AyalaA.et al (2011). A role for specific collagen motifs during wound healing and inflammatory response of fibroblasts in the teleost fish gilthead seabream.Mol. Immunol.48826–834. 10.1016/j.molimm.2010.12.004
13
ChangM. C.LinL. D.Zwei-Ching ChangJ.HuangC. F.ChuangF. H.LeeJ. J.et al (2012). Regulation of vascular cell adhesion molecule-1 in dental pulp cells by interleukin-1beta: the role of prostanoids.J. Endod.38774–779. 10.1016/j.joen.2012.02.030
14
ChristmannR. B.Sampaio-BarrosP.StifanoG.BorgesC. L.De CarvalhoC. R.KairallaR.et al (2013). Key roles for interferon- and TGF-beta-regulated genes, and macrophage activation in progressive lung fibrosis associated with Systemic Sclerosis.Arthritis Rheum. 10.1002/art.38288[Epub ahead of print].
15
DanckwardtS.HentzeM. W.KulozikA. E. (2013). Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond.J. Mol. Med.911257–1271. 10.1007/s00109-013-1074-5
16
DengJ.WangX. R.QianF.VogelS.XiaoL.RanjanR.et al (2012). Protective role of reactive oxygen species in endotoxin-induced lung inflammation through modulation of IL-10 expression.J. Immunol.1885734–5740. 10.4049/jimmunol.1101323
17
DesmouliereA.RedardM.DarbyI.GabbianiG. (1995). Apoptosis mediates the decrease in cellularity during the transition between granulation-tissue and scar.Am. J. Pathol.14656–66.
18
DevalarajaR. M.NanneyL. B.QianQ. H.DuJ. G.YuY. C.DevalarajaM. N.et al (2000). Delayed wound healing in CXCR2 knockout mice.J. Invest. Dermatol.115234–244. 10.1046/j.1523-1747.2000.00034.x
19
DiegelmannR. F.EvansM. C. (2004). Wound healing: an overview of acute, fibrotic and delayed healing.Front. Biosci. 9283–289. 10.2741/1184
20
DinarelloC. A. (1996). Biologic basis for interleukin-1 in disease.Blood872095–2147.
21
DiPietroL. A. (1995). Wound healing: the role of the macrophage and other immune cells.Shock4233–240. 10.1097/00024382-199510000-00001
22
DuginaT. N.KiselevaE. V.ChistovI. V.UmarovaB. A.StrukovaS. M. (2002). Receptors of the PAR-family as a link between blood coagulation and inflammation.Biochemistry (Mosc.)6765–74. 10.1023/A:1013952114485
23
DunneJ. L.CollinsR. G.BeaudetA. L.BallantyneC. M.LeyK. (2003). Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation.J. Immunol.1716105–6111.
24
ElmoreS. (2007). Apoptosis: a review of programmed cell death.Toxicol. Pathol.35495–516. 10.1080/01926230701320337
25
EmingS. A.KriegT.DavidsonJ. M. (2007). Inflammation in wound repair: molecular and cellular mechanisms.J. Invest. Dermatol.127514–525. 10.1038/sj.jid.5700701
26
FriedS. K.BunkinD. A.GreenbergA. S. (1998). Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid.J. Clin. Endocrinol. Metab.83847–850. 10.1210/jc.83.3.847
27
GabayC.LamacchiaC.PalmerG. (2010). IL-1 pathways in inflammation and human diseases.Nat. Rev. Rheumatol.6232–241. 10.1038/nrrheum.2010.4
28
GallucciR. M.SimeonovaP. P.MathesonJ. M.KommineniC.GurielJ. L.SugawaraT.et al (2000). Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice.FASEB J.142525–2531. 10.1096/fj.00-0073com
29
GregoryC. D. (2013). Inflammation and cancer revisited: an hypothesis on the oncogenic potential of the apoptotic tumor cell.Autoimmunity46312–316. 10.3109/08916934.2012.755961
30
HellbergC.OstmanA.HeldinC. H. (2010). PDGF and vessel maturation.Recent Results Cancer Res.180103–114. 10.1007/978-3-540-78281-0_7
31
HotamisligilG. S.ShargillN. S.SpiegelmanB. M. (1993). Adipose expression of tumor necrosis factor-alpha – direct role in obesity-linked insulin resistance.Science25987–91. 10.1126/science.7678183
32
HuangJ. S.WangY. H.LingT. Y.ChuangS. S.JohnsonF. E.HuangS. S. (2002). Synthetic TGF-beta antagonist accelerates wound healing and reduces scarring.FASEB J.161269–1270.
33
HuW.XiaL. J.ChenF. H.WuF. R.TangJ.ChenC. Z.et al (2012). Recombinant human endostatin inhibits adjuvant arthritis by down-regulating VEGF expression and suppression of TNF-alpha, IL-1beta production.Inflamm. Res.61827–835. 10.1007/s00011-012-0477-z
34
KirsnerR. S.EaglsteinW. H. (1993). The Wound-Healing Process.Dermatol. Clin.11629–640.
35
LiA. L.YangY. Y.GaoC.LuJ. Y.JeongH. W.LiuB. H.et al (2013). A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.J. Clin. Invest.1234195–4207. 10.1172/JCI62891
36
LiF.HuangQ.ChenJ.PengY. L.RoopD. R.BedfordJ. S.et al (2010). Apoptotic cells activate the “Phoenix Rising” pathway to promote wound healing and tissue regeneration.Sci. Signal. 3:ra13. 10.1126/scisignal.2000634
37
LiL.YanB.ShiY. Q.ZhangW. Q.WenZ. L. (2012). Live imaging reveals differing roles of macrophages and neutrophils during zebrafish tail fin regeneration.J. Biol. Chem.28725353–25360. 10.1074/jbc.M112.349126
38
LibbyP.RidkerP. M.MaseriA. (2002). Inflammation and atherosclerosis.Circulation1051135–1143. 10.1161/hc0902.104353
39
LynchS. E.NixonJ. C.ColvinR. B.AntoniadesH. N. (1987). Role of platelet-derived growth-factor in wound-healing – synergistic effects with other growth-factors.Proc. Natl. Acad. Sci. U.S.A.847696–7700. 10.1073/pnas.84.21.7696
40
MargadantC.SonnenbergA. (2010). Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing.EMBO Rep.1197–105. 10.1038/embor.2009.276
41
MartinP. (1997). Wound healing – aiming for perfect skin regeneration.Science27675–81. 10.1126/science.276.5309.75
42
MaslinskaD.GajewskiM. (1998). Some aspects of the inflammatory process.Folia Neuropathol.36199–204.
43
MaxsonS.LopezE. A.YooD.Danilkovitch-MiagkovaA.LerouxM. A. (2012). Concise review: role of mesenchymal stem cells in wound repair.Stem Cells Transl. Med.1142–149. 10.5966/sctm.2011-0018
44
MorescalchiF.DuseS.GambicortiE.RomanoM. R.CostagliolaC.SemeraroF. (2013). Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid.Mediators Inflamm. 2013:269787. 10.1155/2013/269787
45
MullerA. K.MeyerM.WernerS. (2012). The roles of receptor tyrosine kinases and their ligands in the wound repair process.Semin. Cell Dev. Biol.23963–970. 10.1016/j.semcdb.2012.09.015
46
NemenoffR. (2012). Wound healing: a role for HDACs in inhibition of fibroblast proliferation through repression of PDGF receptor-alpha. Focus on “Repression of PDGF-R-alpha after cellular injury involves TNF-alpha, formation of a c-Fos-YY1 complex, and negative regulation by HDAC”. Am. J. Physiol.302C1588–C1589. 10.1152/ajpcell.00095.2012
47
OuyangW. J.RutzS.CrellinN. K.ValdezP. A.HymowitzS. G. (2011). Regulation and functions of the IL-10 family of cytokines in inflammation and disease.Annu. Rev. Immunol.2971–109. 10.1146/annurev-immunol-031210-101312
48
ParkJ. E.BarbulA. (2004). Understanding the role of immune regulation in wound healing.Am. J. Surg.18711S–16S. 10.1016/S0002-9610(03)00296-4
49
PesceM.PatrunoA.SperanzaL.RealeM. (2013). Extremely low frequency electromagnetic field and wound healing: implication of cytokines as biological mediators.Eur. Cytokine Netw.241–10. 10.1684/ecn.2013.0332
50
PierceG. F.MustoeT. A.AltrockB. W.DeuelT. F.ThomasonA. (1991). Role of platelet-derived growth-factor in wound-healing.J. Cell. Biochem.45319–326. 10.1002/jcb.240450403
51
PriceR. D.Das-GuptaV.HarrisP. A.LeighI. M.NavsariaH. A. (2004). The role of allogenic fibroblasts in an acute wound healing model.Plast. Reconstr. Surg.1131719–1729. 10.1097/01.PRS.0000117367.86893.CE
52
PunchardN. A.WhelanC. J.AdcockI. (2004). The journal of inflammation.J. Inflamm. (Lond.)1:1. 10.1186/1476-9255-1-1
53
Rubio-PerezJ. M.Morillas-RuizJ. M. (2012). A review: inflammatory process in Alzheimer’s disease, role of cytokines.ScientificWorldJournal2012:756357. 10.1100/2012/756357
54
SakuraiT.HeG.MatsuzawaA.YuG. Y.MaedaS.HardimanG.et al (2008). Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis.Cancer Cell14156–165. 10.1016/j.ccr.2008.06.016
55
SaraivaMO’GarraA. (2010). The regulation of IL-10 production by immune cells.Nat. Rev. Immunol.10170–181. 10.1038/nri2711
56
SbarsiI.FalconeC.BoiocchiC.CampoI.ZorzettoM.De SilvestriA.et al (2007). Inflammation and atherosclerosis: The role of TNF and TNF receptors polymorphisms in coronary artery disease.Int. J. Immunopathol. Pharmacol.20145–154.
57
SchottJ. M.ReveszT. (2013). Inflammation in Alzheimer’s disease: insights from immunotherapy.Brain1362654–2656. 10.1093/brain/awt231
58
SgoncR.GruberJ. (2013). Age-related aspects of cutaneous wound healing: a mini-review.Gerontology59159–164. 10.1159/000342344
59
SindrilaruA.PetersT.SchymeinskyJ.OreshkovaT.WangH. L.GompfA.et al (2009). Wound healing defect of Vav3(-/-) mice due to impaired beta(2)-integrin-dependent macrophage phagocytosis of apoptotic neutrophils.Blood1135266–5276. 10.1182/blood-2008-07-166702
60
SingerA. JClarkR. a. F. (1999). Mechanisms of disease – cutaneous wound healing.N. Engl. J. Med.341738–746. 10.1056/NEJM199909023411006
61
StrukovaS. (2006). Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Front. Biosci.11:59–80. 10.2741/1780
62
TangE. H. C.LibbyP.VanhoutteP. M.XuA. M. (2012). Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases.J. Cardiovasc. Pharmacol.59116–123. 10.1097/FJC.0b013e3182244a12
63
TatlerA. L.JenkinsG. (2012). TGF-beta activation and lung fibrosis.Proc. Am. Thorac. Soc.9130–136. 10.1513/pats.201201-003AW
64
TettamantiG.GrimaldiA.RinaldiL.ArnaboldiF.CongiuT.ValvassoriR.et al (2004). The multifunctional role of fibroblasts during wound healing in Hirudo medicinalis (Annelida, Hirudinea).Biol. Cell96443–455. 10.1016/j.biolcel.2004.04.008
65
WahlS. M.MccartneyfrancisN.MergenhagenS. E. (1989). Inflammatory and immunomodulatory roles of TGF-beta.Immunol. Today10258–261. 10.1016/0167-5699(89)90136-9
66
WilgusT. A. (2008). Immune cells in the healing skin wound: influential players at each stage of repair.Pharmacol. Res.58112–116. 10.1016/j.phrs.2008.07.009
67
WilsonS. E.ChaurasiaS. S.MedeirosF. W. (2007). Apoptosis in the initiation, modulation and termination of the corneal wound healing response.Exp. Eye Res.85305–311. 10.1016/j.exer.2007.06.009
68
XingZ.GauldieJ.CoxG.BaumannH.JordanaM.LeiX. F.et al (1998). IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.J. Clin. Invest.101311–320. 10.1172/JCI1368
Summary
Keywords
apoptosis, inflammation, wound healing, cellular physiology, wound repair
Citation
Wu Y-S and Chen S-N (2014) Apoptotic cell: linkage of inflammation and wound healing. Front. Pharmacol. 5:1. doi: 10.3389/fphar.2014.00001
Received
07 November 2013
Accepted
03 January 2014
Published
21 January 2014
Volume
5 - 2014
Edited by
Annalisa Bruno, Gabriele d’Annunzio University of Chieti-Pescara, Italy
Reviewed by
Bernhard H. Rauch, University of Greifswald, Germany; Emanuela Marcantoni, Gabriele d’Annunzio University of Chieti-Pescara, Italy
Copyright
© 2014 Wu and Chen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shiu-Nan Chen, College of Life Science, National Taiwan University, No.1, Section 4, Roosevelt Road, Da’ an, Taipei 10617, Taiwan e-mail: d97b45004@ntu.edu.tw;snchen@ntu.edu.tw
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.